5Hujoel PP, Drangsholt M, Spiekeman C, et al. Periodontal disease and coronary heart disease risk. JAMA,2000,284 : 1406-1410.
6De Stefano F,Anda RF, Kahn HS, et al Dental disease and risk of coronary heart disease and mortality. BMJ, 1993,306:688-691.
7Beck JD, Elter JR, Heiss G, et al Relationship of periodontal disease to carotid artery intima-media wall thickness:the atherosclerosis risk in communities ( ARIC ) study. Arterioscler Thromb Vasc Biol, 2001,21:1816-1822.
8Angeli F, Verdeeehia P, Pellegrino C, et al. Association between periodontal disease and left ventriele mass in essential hypertension. Hypertension, 2003, 41:488-492.
9Arbes S J, Slade GD, Beck JD. Association between extent of periodontal attachment loss and self 2 reported history of heart attack : an analysis of NHANES Ⅲ data. J Dent Res, 1999, 78: 1777- 1782.
10D' Aiuto F, ParkarM, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatorymarkers. J Dent Res, 2004,83 : 156 - 160.
2Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group[ J ]. N Engl J Med, 1995, 333(20) : 1301 - 1307.
3Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/ Texas Coronary Atherosclemsis Prevention Study [ J ]. JAMA, 1998, 279(20) : 1615 - 1622.
4The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [ J]. Lancet, 1994, 344(8934) : 1383 - 1389.
5Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels cholesterol and recurrent events trial investigators[J]. N Engl J Med, 1996, 335 (14): 1001-1009.
6The Long-Term Intervention with Pravastatin in Ischaemic Disease (L IP-D) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels [ J ]. N Engl J Med, 1998, 339(19) : 1349 -1357.
7Mattila KJ, Nieminen M, Valtonen V, et al. Association between dental health and acute myocardial infarction [ J ]. BMJ, 1989, 298 (6676) : 779 -785.
8De Stefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality [ J ] . BMJ, 1993, 306 (6879) : 688 -697.
9Mattila K J, Valle MS, Nieminen MS, et al. Dental infections and coronary atherosclerosis [ J ]. Atherosclerosis, 1993, 103 ( 2 ) : 205 -211.
10Arbes SJ, Slade GD, Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES Ⅲ data[J]. J Dent Res, 1999, 78 (12) :1777 - 1781.
